Literature DB >> 15790673

Time trends in the treatment and survival of recurrences from colorectal cancer.

F Guyot1, J Faivre, S Manfredi, B Meny, C Bonithon-Kopp, A M Bouvier.   

Abstract

BACKGROUND: Little is known about the management of recurrences from colorectal cancer at a population level.
MATERIALS AND METHODS: Data was obtained from the population-based cancer registry of Cote d'Or (Burgundy, France) over a 28-year period. Univariate and multivariate analyses were performed to analyse trends in treatment and survival for local recurrence and distant metastases.
RESULTS: The proportion of patients resected for cure increased from 6.7% (1976-1984) to 23.7% (1994-2003; P <0.001) for distant metastases and from 15.9% to 58.1% (P <0.001) for local recurrence. Age and period of diagnosis were independent factors associated with a resection for cure. Rectal cancer local recurrence was less often resected for cure than colon cancer local recurrence (P=0.05). Long-term survival was observed only after resection for cure: 5-year relative survival rates were 36.1% for local recurrence and 24.0% for distant metastases. In the multivariate analysis, survival decreased with age and increased over time but significantly only over the last study period. Surgical resection and palliative chemotherapy were other determinants of prognosis for distant metastases whereas surgical resection and palliative radiotherapy did influence the prognosis for local recurrence.
CONCLUSION: Substantial advances in the management of recurrences have been achieved over time. More effective treatments and mass screening represent promising approaches to decrease this problem.

Entities:  

Mesh:

Year:  2005        PMID: 15790673     DOI: 10.1093/annonc/mdi151

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  30 in total

Review 1.  Surveillance of patients following surgery with curative intent for colorectal cancer.

Authors:  Steven Gan; Katherine Wilson; Paul Hollington
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

2.  Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.

Authors:  Yun-Feng Yao; Zhi Yang; Zhen-Fu Li; Jin Gu
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

Review 3.  Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the Evidence.

Authors:  Gonzalo Tapia Rico; Amanda R Townsend; Vy Broadbridge; Timothy J Price
Journal:  Drugs Aging       Date:  2017-03       Impact factor: 3.923

4.  The dynamics of colorectal cancer management in 17 countries.

Authors:  Panos Kanavos; Willemien Schurer
Journal:  Eur J Health Econ       Date:  2010-01

5.  [Efficacy and safety of carbon-ion radiotherapy for locally recurrent rectal cancer: results of the J‑CROS Study 1404 Rectum].

Authors:  Christina Jentsch; Esther G C Troost
Journal:  Strahlenther Onkol       Date:  2019-08       Impact factor: 3.621

6.  Site-dependent E-cadherin cleavage and nuclear translocation in a metastatic colorectal cancer model.

Authors:  María Virtudes Céspedes; María Jesús Larriba; Miguel Angel Pavón; Patricia Alamo; Isolda Casanova; Matilde Parreño; Anna Feliu; Francesc Josep Sancho; Alberto Muñoz; Ramón Mangues
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

7.  Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts.

Authors:  Rita Fior; Vanda Póvoa; Raquel V Mendes; Tânia Carvalho; António Gomes; Nuno Figueiredo; Miguel Godinho Ferreira
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-23       Impact factor: 11.205

8.  Serum Tumor Marker Use in Patients With Advanced Solid Tumors.

Authors:  Melissa K Accordino; Jason D Wright; Sowmya Vasan; Alfred I Neugut; Ana Tergas; Jim C Hu; Dawn L Hershman; Melissa K Accordino; Jason D Wright; Sowmya Vasan; Alfred I Neugut; Ana Tergas; Jim C Hu; Dawn L Hershman
Journal:  J Oncol Pract       Date:  2015-09-15       Impact factor: 3.840

Review 9.  Colorectal cancer, one entity or three.

Authors:  Feng-ying Li; Mao-de Lai
Journal:  J Zhejiang Univ Sci B       Date:  2009-03       Impact factor: 3.066

10.  Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers.

Authors:  W M U van Grevenstein; L J Hofland; M E E van Rossen; P M van Koetsveld; J Jeekel; C H J van Eijck
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.